Ligand validation:7ZOY

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7ZOY_LFA_A_604	43%	100%	0.12	0.924	0.1	0.08	-	-	2	0	55%	0.55
7ZOY_LFA_A_607	28%	98%	0.115	0.827	0.1	0.16	-	-	0	0	65%	0.65
7ZOY_LFA_A_610	26%	100%	0.133	0.872	0.1	0.08	-	-	2	0	45%	0.45
7ZOY_LFA_A_606	25%	99%	0.117	0.87	0.12	0.08	-	-	0	0	35%	0.35
7ZOY_LFA_A_609	24%	100%	0.161	0.86	0.09	0.07	-	-	0	0	60%	0.6
7ZOY_LFA_A_603	23%	100%	0.168	0.828	0.08	0.06	-	-	0	0	80%	0.8
7ZOY_LFA_A_605	16%	96%	0.135	0.834	0.14	0.22	-	-	0	0	25%	0.25
7ZOY_LFA_A_612	15%	100%	0.163	0.795	0.09	0.07	-	-	0	0	60%	0.6
7ZOY_LFA_A_608	15%	100%	0.202	0.789	0.08	0.05	-	-	2	0	85%	0.85
7ZOY_LFA_A_613	7%	87%	0.173	0.777	0.23	0.45	-	-	0	0	20%	0.2
7ZOY_LFA_A_617	4%	100%	0.202	0.707	0.1	0.09	-	-	0	0	35%	0.35
7ZOY_LFA_A_614	4%	100%	0.213	0.692	0.1	0.08	-	-	0	0	40%	0.4
7ZOY_LFA_A_618	3%	100%	0.248	0.649	0.09	0.06	-	-	0	0	55%	0.55
7ZOU_LFA_A_602	46%	97%	0.126	0.879	0.07	0.25	-	-	0	0	90%	0.9
7ZOV_LFA_A_612	38%	99%	0.128	0.902	0.09	0.12	-	-	2	0	60%	0.6
7ZOW_LFA_A_1018	34%	100%	0.104	0.858	0.09	0.09	-	-	0	0	60%	0.6
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.